期刊文献+

Th17/Treg平衡失调及其相关因子在乳腺癌浸润转移的相关性研究 被引量:5

The Imbalance of Th17/Treg Cells and Related Cytokines in Breast Cancer and Its Relationship with Infiltration and Metastasis
在线阅读 下载PDF
导出
摘要 目的研究乳腺癌患者外周血中Th17细胞、Treg细胞及相关细胞因子的表达水平,探讨其表达与淋巴结转移的关系.方法运用流式细胞分析技术(FACS)检测35例术前乳腺癌患者Th17细胞、Treg细胞的比例,采用ELISA法检测相关细胞因子IL-23、IL-10、IL-35、TGF-β的表达水平.结果乳腺癌外周血中Th17细胞和Treg细胞的比例均高于健康对照组(P<0.05),淋巴结转移组Th17细胞和Treg细胞比例均高于无淋巴结转移组(P<0.05),且Treg细胞比Th17细胞升高的更为明显,淋巴结转移患者的Th17/Treg的比值低于无淋巴结转移者(P<0.05),相关细胞因子IL-23、IL-10、TGF-β水平较健康对照组升高,IL-35水平下降,但IL-23在乳腺癌淋巴结转移和非淋巴结转移组无明显差异(P>0.05),而IL-10、TGF-β、IL-35水平在淋巴结转移组和无淋巴结转移组存在差异(P<0.05).结论细胞因子IL-23、IL-10、TGF-β和Th17细胞和Treg细胞的变化趋势相一致,IL-35和Treg细胞的升高呈负相关,说明细胞因子参与了肿瘤微环境的调节,Thl7/Treg平衡失调或许是导致肿瘤进展的因素之一. Objective To investigate expression of the Th17 cells and Treg cells in breast cancer tumor and related cytokines in the peripheral blood,and study its relationship with lymphatic metastasis.Methods Flow cytometry was applied to test Th17 cells and Treg cells in the peripheral blood of both 35 cases of breast cancer and 20 controls.ELASA method was used to test the expression cytokines of IL-23,IL-10,IL-35 and TGF-β.Results The frequency of Th17 cells and Treg cells in breast cancer was significantly higher that in healthy volunteers (P <0.05).The frequency of Th17 cells and Treg cells in patients of lymphatic metastasis was significantly higher that in patients of non-lymphatic metastasis (P<0.05),then Treg cells increased more obviously than Th17 cells.The radio of Th17/Treg cells in patients of lymphatic metastasis was significantly lower than in patients of non-lymphatic metastasis (P<0.05).IL-23,IL-10 and TGF-β expression levels were higher than those in healthy control group (P<0.05),but IL-35 expression levels were lower.There was no significant difference in IL-23 expression between lymphatic metastasis group and non-lymphatic metastasis group (P>0.05),while there were significant differences in expression of IL-10,TGF-β and IL-35 between two groups (P< 0.05).Conclusions The trend of changes in the related cytokines IL-23,IL-1O and TGF-β is in agreement with that of Th17 cells and Treg cells in the peripheral blood of breast cancer.The rise of IL-35 and Treg cells shows a negative correlation.The imbalance of Th17/Treg may be one of the factors leading to tumour progression.
出处 《昆明医科大学学报》 CAS 2014年第8期89-92,共4页 Journal of Kunming Medical University
基金 陕西省卫生厅科研基金资助项目(2012D19)
关键词 TH17细胞 TREG细胞 乳腺癌 IL-23 IL-10 TGF-β IL-35 Th17 cell Treg cell Breast cancer IL-23 IL-10 TGF-β IL-35
  • 相关文献

参考文献11

  • 1COLOTrA F,ALLAVENA P,SCIA A,et al. Caneer-rel- lated inflammation,the seventh hallmark of cancer:links to genetic instability [ J ]. Carcinogenesis, 2009,30:1 073 - 1 081.
  • 2KORN T,BETYELLI E,OUKKA M,et al.IL-17 and Thl7 Cells [ J ]. Annu Rev Immunol, 2009,27:485 - 517.
  • 3LARMONIER N,MARRON M,ZENG Y,et al. Tumor- derived CD4+CD25regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunothe, 2007,56( 1 ):48-59.
  • 4SU X,YE J,HSUEH E C,et al.Tumor microenvironment direct the recruitment and expansion of human Thl7 cells [ J ]. J Immunol, 2010,184 ( 3 ): 1 630- 1 641.
  • 5LE GS, BASTUJI-GARIN S, ALOLOU N, et al. High pre- valence of Foxp3 and IL-17 in MMR-proficient eolorectal carcinomas[ J ]. Cut, 2008,57(6):772-779.
  • 6NUMASAKI, M, FUKUSHI J, ONO M, et al.Interleukin-17 promotes angiogenesis and tumor growth [J]. Blood, 2003,101 (7) : 2 620 - 2 627.
  • 7SONIAA. Perez, Michael V. Karamouzis, Dimosthenes V. Skarlos, et a1.CD4+CD25+Regulatory T-Cell Frequency in HER-2/neu (HER)-Positive and HER-Negative Advanced-Stage Breast Cancer Patients [ J ]. J Clin Cancer Res,2007,13(9):2 714-2 721.
  • 8OKITA R,SAEKI T,TAKASHIMA S,et al. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non small cell lung cancer [J ]. Oncol Rep, 2005,14( 5 ): 1 269- 1 273.
  • 9ANDREW J, RECH, ROSEMARIE MICK, et al. Homeos- tasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer.Cancer Immunology, Immunotherapy, 2010,59:599- 607.
  • 10CARDILLO M R,YAP E, Castagna G.Molecular genetic analysis of TGF betal in breast cancer [J]. J E:xp Clin Cancer Res, 1997,16( 1 ):57-63.

同被引文献45

  • 1袁野,庞伟毅.细胞焦亡与乳腺癌研究进展[J].世界最新医学信息文摘,2019,0(92):91-91. 被引量:3
  • 2潘洪平.银杏叶制剂药理作用和临床应用研究进展[J].中国中药杂志,2005,30(2):93-96. 被引量:92
  • 3Collison LW, Workman CJ, Kuo "IT, et al. "lhe inhibitory cytokine IL-35 contributes to regulatory T-cell function[J]. Nature, 2007, 450(7169): 566-569.
  • 4Wang Z, Liu JOa Liu Z, et al. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis[J]. J Immunol, 2013, 190(5): 2415-2423.
  • 5Long J, Zhang X, Wen M, et al. IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells[J]. Biochem Biophys Res Commun, 2013, 430( 1): 364-369.
  • 6ZengJC, Zhang Z, Li TY, et al. Assessing the role of IL-35 in colorectal cancer progression and prognosis[J], lntJ Clin Exp Pathol, 2013, 6(9): 1806-1816.
  • 7Strauss L, Bergmann C, Szczepanski M, et al. A unique subset of CD4+CD25higbFoxp3+ T cells secreting interleukin-10 and transforming growth factor-betal mediates suppression in the tumormicroenvironment[J]. Clin Cancer Res, 2007, 13(15 Pt 1): 4345-4354.
  • 8Eller K, Wolf D, Huber JM, et al. IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression [ J ]. J Immunol, 2011, 186 ( 1 ): 83-91.
  • 9Liao KL, Bai XF, Friedman A. Mathematical modeling of Interleukin-35 promoting tumor growth and angiogenesis [J]. PLoS One, 2014, 9(10): e110126.
  • 10Wu H, Li P, Shao N, et al. Aberrant expression of Treg-associated cytokine 1L-3S along with IL-10 and TGF- in acute myeloid leukemia[J]. Oncol Lett, 2012, 3(5): 1119-1123.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部